Demonstration of the renal venous system at routine nephroangiography. A comparison between metrizoate, metrizamide and ioxaglate.
The demonstration of renal veins during routine nephroangiography was retrospectively investigated and blindly scored in 60 patients. Three different types of contrast media were used: one high-osmolar ionic monomeric (metrizoate) and two low-osmolar, the non-ionic monomeric (metrizamide) and the ionic monoacidic dimeric (ioxalate). The renal veins and the inferior vena cava were significantly better and more often demonstrated when ioxaglate was used compared with metrizoate and metrizmide. There was no significant difference between metrizoate and metrizamide. Following semiselective renal artery injection, the main renal veins were demonstrated with a diagnostically acceptable quality with ioxaglate in 76 per cent, with metrizamide in 40 per cent and with metrizoate in 29 per cent. On selective renal artery injection the demonstration of renal veins increased to 85 per cent with ioxaglate and remained unchanged with metrizmide (38%) and metrizoate (26%). Semiselective or selective nephroangiography with ioxaglate at an ordinary dose was in most patients sufficient to allow evaluation of renal vein involvement in disease, rendering high dose selective nephroangiography or selective nephrophlebography unnecessary. A slower diffusion rate of ioxaglate compared with metrizoate and metrizamide is considered to be the major explanation for the better demonstration of the renal veins.
D000328:Adult; D000368:Aged; D000792:Angiography / Q000379:methods; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007463:Iodobenzoates; D007485:Ioxaglic Acid; D007668:Kidney / Q000000981:diagnostic imaging; D007674:Kidney Diseases / Q000000981:diagnostic imaging; D008297:Male; D008793:Metrizamide / Q000008:administration & dosage; D008794:Metrizoic Acid / Q000008:administration & dosage; D008875:Middle Aged; D012077:Renal Artery; D012079:Renal Circulation; D012082:Renal Veins / Q000000981:diagnostic imaging*; D012189:Retrospective Studies; D014283:Triiodobenzoic Acids / Q000008:administration & dosage; D014682:Vena Cava, Inferior / Q000000981:diagnostic imaging
D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D008794:Metrizoic Acid; D008793:Metrizamide; D007485:Ioxaglic Acid